Vasopressin receptor antagonists: From pivotal trials to current practice

Keyphrases

• Pivotal Trial 100%
• Vasopressin Receptor Antagonists 100%
• Acute Heart Failure Syndrome 100%
• Vasopressin Antagonists 100%
• Heart Failure 66%
• Improved Outcomes 33%
• Clinical Application 33%
• Chronic Heart Failure 33%
• Antagonism 33%
• Mechanism of Action 33%
• Hospitalization Rate 33%
• Patients with Heart Failure 33%
• Mortality Rate 33%
• Health Problems 33%
• Clinical Trial Data 33%
• Congestion 33%
• Long-term Morbidity 33%
• Loop Diuretics 33%
• Acute Heart Failure 33%
• Receptor Antagonism 33%
• Unmet Needs 33%
• Large Trials 33%
• Diuresis 33%
• Economic Problems 33%
• Data Recommendation 33%
• Arginine Vasopressin Antagonist 33%
• Vasopressin Receptor 33%
• V2 Receptor 33%
• Current Recommendations 33%
• Morbidity Mortality 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Failure 100%
• Acute Heart Failure 100%
• Vasopressin Antagonist 100%
• Vasopressin Receptor Antagonist 100%
• Syndrome 75%
• Clinical Trial 25%
• Physical Disease by Body Function 25%
• Argipressin 25%
• Loop Diuretic Agent 25%
• Vasopressin V2 Receptor 25%
• Vasopressin Receptor 25%